Reuters - HgCapital Sells Mercury Pharma to Cinven

Investor HgCapital has sold British pharmaceutical company Mercury Pharma to private equity firm Cinven for $732 million, writes Reuters. HgCapital bought the 25-year-old pharmaceutical firm, which sells niche prescription off-patent products in the UK, Ireland and the Netherlands, in 2009.

DealsNorth AmericaUSBriefs